Hunan Er-Kang Pharmaceutical Co., Ltd
SHZ: 300267.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Qingrong Sun
- Employees
- 1,497
- Headquarters
- Liuyang, China
- IPO year
- 2011
- Market cap
- CN¥9.0B
- Website
- https://www.hnerkang.com
Loading 300267…
Loading profile data…Frequently asked questions about 300267
What does Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ) do?
Hunan Er-Kang Pharmaceutical Co., Ltd manufactures and sells APIs, finished drug products, and pharmaceutical excipients in China and internationally. Its APIs include glycerin, dilute hydrochloric acid, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. The company's finished drugs primarily comprise sulb...
Where does 300267.SZ trade?
Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300267.SZ in?
Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Hunan Er-Kang Pharmaceutical Co., Ltd?
Qingrong Sun is the chief executive officer of Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ).
Where is Hunan Er-Kang Pharmaceutical Co., Ltd headquartered?
Hunan Er-Kang Pharmaceutical Co., Ltd is headquartered in China.
Does 300267.SZ pay a dividend?
Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 300267.SZ go public?
Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ) completed its initial public offering in 2011.